Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
3.050
+0.100 (3.39%)
At close: Jun 26, 2026, 4:00 PM EDT
2.990
-0.060 (-1.97%)
After-hours: Jun 26, 2026, 7:37 PM EDT
Equillium Employees
As of December 31, 2025, Equillium had 15 total employees, including 14 full-time and 1 part-time employees. The number of employees decreased by 20 or -57.14% compared to the previous year.
Employees
15
Change (1Y)
-20
Growth (1Y)
-57.14%
Revenue / Employee
n/a
Profits / Employee
-$1,270,333
Market Cap
192.84M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| MediWound | 121 |
| Arcturus Therapeutics Holdings | 111 |
| Nkarta | 108 |
| Compugen | 75 |
| Precision BioSciences | 66 |
| NovaBridge Biosciences | 30 |
| Unicycive Therapeutics | 22 |
EQ News
- 9 days ago - EQ Works Expands Multi-Year Partnership with Leading Canadian Publisher to Include SaaS License for ClearLake - Accesswire
- 25 days ago - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Equillium to Participate in the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Equillium price target raised to $7 from $6 at Raymond James - TheFly
- 4 weeks ago - Leerink upgrades Equillium on ‘supportive’ ulcerative colitis data - TheFly
- 4 weeks ago - Equillium upgraded to Outperform from Market Perform at Leerink - TheFly
- 4 weeks ago - Equillium Transcript: Status update - Transcripts
- 4 weeks ago - Equillium Slides: Status update - Filings